VIA·L
‹ Todos los artículos

Café antes de las 14:00, noche sin alcohol, cena temprana: por qué funciona

3 minutos de lectura

Es uno de los pasos más sencillos del «Foco de la semana», y uno de los más eficaces para el sueño. No se trata de añadir nada, sino de quitar tres cosas que estropean la noche sin que te des cuenta.

Por qué funciona

El café mantiene el cuerpo «encendido». La cafeína sube las hormonas del estrés y no deja que bajen al llegar la tarde. Actúa durante mucho tiempo, así que una taza a las cuatro de la tarde dificulta dormirse a medianoche. El límite está en torno a las 14:00, es decir, 8–9 horas antes de dormir.

El alcohol es un «falso amigo». Una copa por la noche ayuda a dormirse, pero corta la segunda mitad de la noche: más despertares, peor recuperación. Empeora los sofocos incluso en pequeñas cantidades, y en la perimenopausia descontrola la ansiedad: calma durante una hora y luego todo va a peor.

Cenar tarde impide que el cuerpo se enfríe y se calme. La última comida copiosa, tres horas antes de acostarte.

Cómo hacerlo

Qué puede dificultarlo

Qué esperar

No te fijes en una sola noche, sino en una semana: cuánto tardas en dormirte, cuántas veces te despiertas, cómo te sientes por la mañana. Anota tu sueño y tus sofocos en VIA-L: así verás la diferencia en números, no solo en sensaciones.

A quién ayuda este paso

A quienes duermen mal, tienen sofocos nocturnos y se levantan cansadas. A menudo va junto con el paso «Levantarse a la misma hora y luz por la mañana».

En qué se basa

Este artículo se basa en temas de la base de conocimiento de VIA-L. Estos son los estudios publicados que hay detrás:

  1. Cognitive Behavioural Therapeutics for Insomnia Symptoms in the Perimenopause Through to the Early Postmenopausal Period — The Cochrane Database of Systematic Reviews, 2026 doi
  2. Insomnia and women: exploring vulnerability, impact, and intervention — Sleep & Breathing = Schlaf & Atmung, 2026 doi
  3. OSA in Women: Associations With Reproductive Aging and Screening Challenges — Chest, 2026 doi
  4. Pharmacological and Non-Pharmacological Treatments for Chronic Insomnia in Perimenopausal and Postmenopausal Women: A Systematic Review and Meta-Analysis — Sleep Medicine, 2026 doi
  5. Reframing menopause and menopause hormone therapy as opportunities for healthy aging — Science, 2026 doi
  6. Cognitive-Behavioral, Acceptance-Based, and Mindfulness-Based Interventions for Psychological and Sleep-Related Symptoms During Menopause: A Systematic Review — Acta Psychologica, 2026 doi
  7. Integrative Approaches to Perimenopause — The American Journal of Medicine, 2026 doi
  8. Effectiveness of Non-Pharmacological Interventions for Insomnia Related to Natural Menopause: A Meta-Analysis of Randomized Controlled Trials — Maturitas, 2026 doi
  9. A Digital Mindfulness Intervention Improves Sleep Efficiency and Heart Rate Variability in Healthy Adults — Scientific Reports, 2026 doi
  10. Hormonal Modulation With Withania Somnifera: Systematic Review and Meta-Analysis of Randomized-Controlled Trials — Planta Medica, 2026 doi
  11. Nutritional Modulators of Sleep: A Narrative Review of Vitamins, Minerals, Amino Acids, and Their Neurobiological and Chronoepigenetic Mechanisms — Chronobiology International, 2026 doi
  12. Evaluating Tools for Assessing Mental Health Disorders in Perimenopausal Women — International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics, 2026 doi
Ver todos (113)
  1. FIGO Best Practice Recommendations for the Mental Health of Women at Menopausal Age — International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics, 2026 doi
  2. Cognitive-Behavioral Interventions for (Peri)menopausal Symptoms: A Scoping Review of Interventions Characteristics and Content — Patient Education and Counseling, 2026 doi
  3. Pathogenesis and Potential Therapies for Perimenopausal Depression: Insights From the Estrogen-Gut Microbiota Axis — Frontiers in Neuroendocrinology, 2026 doi
  4. Depression — Lancet (London, England), 2026 doi
  5. Recent Advances in the Relationship Between Mental Symptoms in Postmenopausal Women and Estrogen Fluctuations — Journal of Psychosomatic Obstetrics and Gynaecology, 2026 doi
  6. Effect of Saffron on Depression, Anxiety and Mood Disorder: A GRADE Assessed Systematic Review and Meta-Analysis of 34 Randomized Controlled Trials — Nutritional Neuroscience, 2026 doi
  7. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: A Phase 3 Randomized Clinical Trial — JAMA Internal Medicine, 2025 doi
  8. Fezolinetant and Elinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms: A Systematic Review and Meta-Analysis — Obstetrics and Gynecology, 2025 doi
  9. Menopause and Movement: Exercise for Better Sleep and Psychological Well-Being-a Systematic Review — Menopause (New York, N.Y.), 2025 doi
  10. Omega-3 Fatty Acids and Sleep: Recent Advances in Understanding Effects and Mechanisms — Current Opinion in Clinical Nutrition and Metabolic Care, 2025 doi
  11. Adrenal Insufficiency in Adults — JAMA, 2025 doi
  12. An Integrative Approach to HPA Axis Dysfunction: From Recognition to Recovery — The American Journal of Medicine, 2025 doi
  13. The Combination of Physical Exercise and Slow-Paced Breathing on Psychophysiological Indices of Emotion Reactivity, Psychosocial Stress Reactivity and Recovery: A Multimodal Investigation — Behaviour Research and Therapy, 2025 doi
  14. Role of Circadian Health in Cardiometabolic Health and Disease Risk: A Scientific Statement From the American Heart Association — Circulation, 2025 doi
  15. Effectiveness of 2 Just-in-Time Adaptive Interventions for Reducing Stress and Stabilizing Cardiac Autonomic Function: Microrandomized Trials — Journal of Medical Internet Research, 2025 doi
  16. Chrononutrition Interventions for Mental Health: Addressing Atypical Depression, Ultra-Processed Food Use Disorder, and Circadian Dysregulation — Frontiers in Psychiatry, 2025 doi
  17. An Examination Into the Effects of a Saffron Extract (Affron) on Mood and General Wellbeing in Adults Experiencing Low Mood: A Randomized, Double-Blind, Placebo-Controlled Trial — The Journal of Nutrition, 2025 doi
  18. Effects of different physical activity interventions on depressive symptoms in menopausal women: a systematic review and network meta-analysis — BMC Public Health, 2025 doi
  19. Effects of physical activity on depressive and anxiety symptoms of women in the menopausal transition and menopause: a comprehensive systematic review and meta-analysis of randomized controlled trials — The International Journal of Behavioral Nutrition and Physical Activity, 2025 doi
  20. Therapeutic Efficacy of Botanicals in Psychological Disorders in Menopausal Women: A Systematic and Scoping Review — Frontiers in Pharmacology, 2025 doi
  21. Exercise as a Therapeutic Strategy for Depression in Menopausal Women: A Metaanalysis of Randomized Trials — Frontiers in Psychiatry, 2025 doi
  22. Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Insomnia in Adults — JAMA Psychiatry, 2024 doi
  23. Network Meta-Analysis Examining Efficacy of Components of Cognitive Behavioural Therapy for Insomnia — Clinical Psychology Review, 2024 doi
  24. Effects of Mind-Body Exercise on Perimenopausal and Postmenopausal Women: A Systematic Review and Meta-Analysis — Menopause (New York, N.Y.), 2024 doi
  25. Stimulus control for insomnia: A systematic review and meta-analysis — J Sleep Res, 2024 doi
  26. Social jetlag and obesity: A systematic review and meta-analysis — Obes Rev, 2024 doi
  27. Shoden Promotes Relief From Stress and Anxiety: A Randomized, Double-Blind, Placebo-Controlled Study on Healthy Subjects With High Stress Levels — Heliyon, 2024 doi
  28. Hypopituitarism — Lancet (London, England), 2024 doi
  29. European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-Induced Adrenal Insufficiency — The Journal of Clinical Endocrinology and Metabolism, 2024 doi
  30. Performance of Dehydroepiandrosterone Sulfate and Baseline Cortisol in Assessing Adrenal Insufficiency — The Journal of Clinical Endocrinology and Metabolism, 2024 doi
  31. The Effectiveness of Psychosocial Interventions on Non-Physiological Symptoms of Menopause: A Systematic Review and Meta-Analysis — Journal of Affective Disorders, 2024 doi
  32. The Risk of Depression in the Menopausal Stages: A Systematic Review and Meta-Analysis — Journal of Affective Disorders, 2024 doi
  33. Neuroendocrine Mechanisms of Mood Disorders During Menopause Transition: A Narrative Review and Future Perspectives — Maturitas, 2024 doi
  34. Promoting Good Mental Health Over the Menopause Transition — Lancet (London, England), 2024 doi
  35. Efficacy and Safety of N-3 Fatty Acids Supplementation on Depression: A Systematic Review and Dose-Response Meta-Analysis of Randomised Controlled Trials — The British Journal of Nutrition, 2024 doi
  36. "Not feeling like myself" in perimenopause - what does it mean? Observations from the Women Living Better survey — Menopause, 2024 doi
  37. Effectiveness of a Saffron and Withania Supplement on Mood in Women With Mild‐to‐Moderate Anxiety During the COVID‐19 Lockdown — Depression and Anxiety, 2024 doi
  38. Effects of Exercise on Depression and Anxiety in Postmenopausal Women: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials — BMC Public Health, 2024 doi
  39. GABA-ergic Modulators: New Therapeutic Approaches to Premenstrual Dysphoric Disorder — CNS Drugs, 2023 doi
  40. The Effect of Caffeine on Subsequent Sleep: A Systematic Review and Meta-Analysis — Sleep Medicine Reviews, 2023 doi
  41. Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial — Lancet, 2023 doi
  42. Oral Micronized Progesterone for Perimenopausal Night Sweats and Hot Flushes a Phase III Canada-Wide Randomized Placebo-Controlled 4 month Trial — Scientific Reports, 2023 doi
  43. Optimizing Sleep Across the Menopausal Transition — Climacteric : The Journal of the International Menopause Society, 2023 doi
  44. Relationship between daytime napping with the occurrence and development of diabetes: a systematic review and meta-analysis — BMJ Open, 2023 doi
  45. Effects of Sleep Fragmentation and Estradiol Decline on Cortisol in a Human Experimental Model of Menopause — The Journal of Clinical Endocrinology and Metabolism, 2023 doi
  46. Changes in Cortisol Awakening Responses (CAR) in Menopausal Women Through Short-Term Marine Healing Retreat Program With Specific Factors Affecting Each CAR Index — PloS One, 2023 doi
  47. Ocimum Tenuiflorum Extract (HOLIXERTM): Possible Effects on Hypothalamic-Pituitary-Adrenal (HPA) Axis in Modulating Stress — PloS One, 2023 doi
  48. Premenstrual Disorders, Timing of Menopause, and Severity of Vasomotor Symptoms — JAMA Network Open, 2023 doi
  49. The Role of Magnesium in Sleep Health: A Systematic Review of Available Literature — Biological Trace Element Research, 2023 doi
  50. Effects of Long-Chain Omega-3 Polyunsaturated Fatty Acids on Reducing Anxiety and/or Depression in Adults; A Systematic Review and Meta-Analysis of Randomised Controlled Trials — Prostaglandins, Leukotrienes, and Essential Fatty Acids, 2023 doi
  51. Efficacy of B-Vitamins and Vitamin D Therapy in Improving Depressive and Anxiety Disorders: A Systematic Review of Randomized Controlled Trials — Nutritional Neuroscience, 2023 doi
  52. Effects of Nutritional Interventions on the Severity of Depressive and Anxiety Symptoms of Women in the Menopausal Transition and Menopause: A Systematic Review, Meta-Analysis, and Meta-Regression — Menopause (New York, N.Y.), 2023 doi
  53. The Therapeutic Impact of Plant-Based and Nutritional Supplements on Anxiety, Depressive Symptoms and Sleep Quality Among Adults and Elderly: A Systematic Review of the Literature — International Journal of Environmental Research and Public Health, 2023 doi
  54. Systematic review and meta-analyses on the effects of afternoon napping on cognition — Sleep Med Rev, 2022 doi
  55. A Portrait of Obstructive Sleep Apnea Risk Factors in 27,210 Middle-Aged and Older Adults in the Canadian Longitudinal Study on Aging — Scientific Reports, 2022 doi
  56. Disruption of Sleep Continuity During the Perimenopause: Associations With Female Reproductive Hormone Profiles — The Journal of Clinical Endocrinology and Metabolism, 2022 doi
  57. Human adaptative behavior to Antarctic conditions: A review of physiological aspects — WIREs Mechanisms of Disease, 2022 doi
  58. Modulation of the Hypothalamic-Pituitary-Adrenal (HPA) Axis by Plants and Phytonutrients: A Systematic Review of Human Trials — Nutritional Neuroscience, 2022 doi
  59. Association of Hormone Therapy With Depression During Menopause in a Cohort of Danish Women — JAMA Network Open, 2022 doi
  60. Mood Disorders and Hormonal Status Across Women's Life: A Narrative Review — Gynecological Endocrinology : The Official Journal of the International Society of Gynecological Endocrinology, 2022 doi
  61. The Effect of a Mediterranean Diet on the Symptoms of Depression in Young Males (The "AMMEND: A Mediterranean Diet in MEN With Depression" Study): A Randomized Controlled Trial — The American Journal of Clinical Nutrition, 2022 doi
  62. Association of Magnesium Intake With Sleep Duration and Sleep Quality: Findings From the CARDIA Study — Sleep, 2022 doi
  63. Behavioral Interventions for Improving Sleep Outcomes in Menopausal Women: A Systematic Review and Meta-Analysis — Menopause (New York, N.Y.), 2022 doi
  64. Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial — JAMA, 2021 doi
  65. Omega-3 Fatty Acids for Depression in Adults — The Cochrane Database of Systematic Reviews, 2021 doi
  66. Omega-3 Long-Chain Polyunsaturated Fatty Acid and Sleep: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Longitudinal Studies — Nutrition Reviews, 2021 doi
  67. Sleep During Menopausal Transition: A 10-Year Follow-Up — Sleep, 2021 doi
  68. Effects of a Short Daytime Nap on the Cognitive Performance: A Systematic Review and Meta-Analysis — Int J Environ Res Public Health, 2021 doi
  69. Diagnosis and Treatment of Luteal Phase Deficiency: A Committee Opinion — Fertility and Sterility, 2021 doi
  70. Chrono-Nutrition: From Molecular and Neuronal Mechanisms to Human Epidemiology and Timed Feeding Patterns — Journal of Neurochemistry, 2021 doi
  71. Effect of magnesium and vitamin B6 supplementation on mental health and quality of life in stressed healthy adults: Post‐hoc analysis of a randomised controlled trial — Stress and Health : Journal of the International Society for the Investigation of Stress, 2021 doi
  72. The Role of Estradiol Fluctuation in the Pathophysiology of Perimenopausal Depression: A Hypothesis Paper — Psychoneuroendocrinology, 2021 doi
  73. Biopsychosocial Predictors of Depressive Symptoms in the Perimenopause-Findings From the Swiss Perimenopause Study — Menopause (New York, N.Y.), 2021 doi
  74. The Allopregnanolone to Progesterone Ratio Across the Menstrual Cycle and in Menopause — Psychoneuroendocrinology, 2020 doi
  75. Hormone Therapy for Postmenopausal Women — The New England Journal of Medicine, 2020 doi
  76. Improving Diet for Psychiatric Patients : High Potential Benefits and Evidence for Safety — Journal of Affective Disorders, 2020 doi
  77. Impact of Estradiol Variability and Progesterone on Mood in Perimenopausal Women With Depressive Symptoms — The Journal of Clinical Endocrinology and Metabolism, 2020 doi
  78. Chronotype and Social Jetlag: A (Self-) Critical Review — Biology (Basel), 2019 doi
  79. Healthy Dietary Indices and Risk of Depressive Outcomes: A Systematic Review and Meta-Analysis of Observational Studies — Molecular Psychiatry, 2019 doi
  80. Efficacy of Omega-3 PUFAs in Depression: A Meta-Analysis — Translational Psychiatry, 2019 doi
  81. Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations — Journal of Women's Health (2002), 2019 doi
  82. Management of Depression in Women — Journal of Women's Health (2002), 2019 doi
  83. Effect of Saffron Supplementation on Symptoms of Depression and Anxiety: A Systematic Review and Meta-Analysis — Nutrition Reviews, 2019 doi
  84. Effect of Omega-3 Supplements on Vasomotor Symptoms in Menopausal Women: A Systematic Review and Meta-Analysis — European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2018 doi
  85. Symptoms of menopause — global prevalence, physiology and implications — Endocrinology, 2018 doi
  86. Effects of Pharmacologic and Nonpharmacologic Interventions on Insomnia Symptoms and Self-Reported Sleep Quality in Women With Hot Flashes: A Pooled Analysis of Individual Participant Data From Four MsFLASH Trials — Sleep, 2018 doi
  87. Positive Psychological Well-Being and Cardiovascular Disease: JACC Health Promotion Series — Journal of the American College of Cardiology, 2018 doi
  88. A New Model for Adrenarche: Inhibition of 3β-Hydroxysteroid Dehydrogenase Type 2 by Intra-Adrenal Cortisol — Hormone Research in Paediatrics, 2018 doi
  89. Effects of Mind⁻Body Exercises (Tai Chi/Yoga) on Heart Rate Variability Parameters and Perceived Stress: A Systematic Review With Meta-Analysis of Randomized Controlled Trials — Journal of Clinical Medicine, 2018 doi
  90. Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial — JAMA Psychiatry, 2018 doi
  91. Omega-3 Versus Isoflavones in the Control of Vasomotor Symptoms in Postmenopausal Women — Gynecological Endocrinology : The Official Journal of the International Society of Gynecological Endocrinology, 2017 doi
  92. Understanding Adaptogenic Activity: Specificity of the Pharmacological Action of Adaptogens and Other Phytochemicals — Annals of the New York Academy of Sciences, 2017 doi
  93. Therapeutic Effects of Phytochemicals and Medicinal Herbs on Depression — BioMed Research International, 2017 doi
  94. Altered Diurnal Pattern of Steroid Hormones in Relation to Various Behaviors, External Factors and Pathologies: A Review — Physiology & Behavior, 2016 doi
  95. Duration of menopausal vasomotor symptoms over the menopause transition — JAMA Intern Med, 2015 doi
  96. Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms — Obstetrics and Gynecology, 2015 doi
  97. Ovarian Hormone Fluctuation, Neurosteroids, and HPA Axis Dysregulation in Perimenopausal Depression: A Novel Heuristic Model — The American Journal of Psychiatry, 2015 doi
  98. Efficacy of Omega-3 for Vasomotor Symptoms Treatment: A Randomized Controlled Trial — Menopause (New York, N.Y.), 2014 doi
  99. Cortisol Stimulates Secretion of Dehydroepiandrosterone in Human Adrenocortical Cells Through Inhibition of 3betaHSD2 — The Journal of Clinical Endocrinology and Metabolism, 2011 doi
  100. Acute Emotional Stress and Cardiac Arrhythmias — JAMA, 2007 doi
  101. Suppression of the Hypothalamic-Pituitary-Ovarian Axis in Normal Women by Glucocorticoids — Biology of Reproduction, 1993 doi

La solidez de esta evidencia varía: hay grandes revisiones y metaanálisis, y también estudios pequeños aislados. Los pasos del artículo son medidas sencillas de autocuidado de bajo riesgo, no un tratamiento, y pueden no servir para todos.

Esto es información general, no una prescripción.

La app VIA-L

VIA-L es una app para mujeres desde los 35 y hombres desde los 40: sueño, energía, ánimo y cuerpo en la etapa de cambios hormonales. Con palabras sencillas, a partir de tus datos — y comprobando qué ayudó.

Todos los artículos de la biblioteca están también en la app.

Sigue leyendo